Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total No. of companies carrying out R&D in Biotechnology 1.061 73 1.133 %Companies according to biotechnology used: Genetic code 30 50 32 %Companies according to biotechnology used: Functional units 40 51 41 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 26 46 27 %Companies according to biotechnology used: Bioprocesses 47 64 48 %Companies according to biotechnology used: Sub-cellular organisms 8 20 8 %Companies according to biotechnology used: Bio-computing 21 31 21 %Companies according to biotechnology used: Nanobiotechnology 14 18 14 %Companies according to biotechnology used: Other 13 10 13 Companies in which biotechnology activities are: Main and/or exclusive 549 15 564 Companies in which biotechnology activities are: A secondary line of business 193 19 212 Companies in which biotechnology activities are: A tool necessary for production 319 38 358 %Company by field(s) of ultimate application of biotechnology use: Human Health 50 51 50 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20 1 19 %Company by field(s) of ultimate application of biotechnology use: Food products 29 36 29 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 18 21 %Company by field(s) of ultimate application of biotechnology use: Environment 13 11 13 %Company by field(s) of ultimate application of biotechnology use: Industry 14 7 13 Personnel in R&D in biotechnology (no. of persons) 7.883 2.823 10.706 Personnel in R&D in biotechnology (no. of persons): Researchers 4.706 1.521 6.227 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 3.177 1.302 4.479 Personnel in R&D in biotechnology (no. of persons): women 4.068 1.727 5.795 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.417 852 3.269 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 1.652 875 2.527 Personnel in R&D in biotechnology (FTE) 5.599 2.117,4 7.716,4 Personnel in R&D in biotechnology (FTE): Researchers 3.511,8 1.091,3 4.603,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.087,2 1.026,1 3.113,3 Personnel in R&D in biotechnology (FTE): women 2.969,5 1.323,4 4.292,9 Personnel in R&D in biotechnology (FTE): (women) Researchers 1.832,2 614,2 2.446,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.137,3 709,2 1.846,5 Internal expenditure on R&D (thousands of euros) 452.121 163.932 616.053 1) By nature of the expense: Current expenses 413.906 160.340 574.245 1.1) Remuneration to researchers 160.779 60.962 221.741 1.2) Remuneration to technicians and assistants 61.960 40.504 102.464 1.3) Other current expenses 191.167 58.874 250.041 2) By nature of the expense: Capital expenses 38.215 3.593 41.808 2.1) Land and buildings 4.988 371 5.359 2.2) Equipment and instruments 26.997 2.493 29.489 2.3) Acquisition of specific R&D software 1.716 590 2.306 2.4) Otros productos de propiedad intelectual específicos para I+D 4.515 139 4.654 1) By origin of the funds: National funds 388.127 123.833 511.960 1.1) Own funds 294.928 87.407 382.335 1.2) From companies 29.072 15.952 45.024 1.3) Public Administration funds 60.976 11.410 72.387 1.4) From Universities 363 0 363 1.5) From non profit private institutions 2.788 9.064 11.851 1) By origin of the funds: Foreign funds 63.994 40.100 104.093 2.1) From EU programmes 18.363 3.462 21.825 2.2) Other foreign funds 45.631 36.638 82.269 Purchase of R&D services in biotechnology (thousands of euros) 88.908 55.434 144.342 Purchase of R&D services in biotechnology (thousands of euros): In Spain 35.758 34.700 70.458 Purchase of R&D services in biotechnology (thousands of euros): Abroad 53.150 20.734 73.885 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 49 29 48 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 13 13 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 15 13 15 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 12 14 12 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 16 14 16 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17 10 16 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16 14 16 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 35 36 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 49 39 49 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 14 18 % Companies that have requested biotechnology patents in Biotechnology 16 12 16 Number of patents requested 570 63 633 % Companies with income of an international origin related to biotechnological activities 24,2 20,7 24 % Turnover representing income of an international origin related to biotechnological activities 6,1 0,9 1,4 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 37,3 75,7 57,3 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 62,7 24,3 42,7 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 96,3 69,4 82,3 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 2,4 29,4 16,5 % Income of an international origin related with activities according to the classification: Operating source abroad 1,1 0,9 1 % Income of an international origin related with activities according to the classification: Other 0,2 0,3 0,3 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute